That means CannTrust’s 72,000 registered medical cannabis patients will have to look to other producers to fill their orders, likely worsening Canada’s supply crunch.

Some provinces had already pulled CannTrust’s recreational products from store shelves.

CannTrust also established a committee comprised of independent board members to investigate the matter.

Full report

Embattled CannTrust halts marijuana sales; Canada’s supply shortfall could worsen